Aehr Test Systems (NASDAQ:AEHR) Issues Quarterly Earnings Results

Aehr Test Systems (NASDAQ:AEHR) released its quarterly earnings results on Tuesday. The semiconductor company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.02, FiscalAI reports. Aehr Test Systems had a negative net margin of 16.63% and a negative return on equity of 4.57%. The business had revenue of $10.31 million for the quarter, compared to the consensus estimate of $10.85 million.

Aehr Test Systems Stock Performance

Shares of NASDAQ AEHR traded down $1.91 during midday trading on Tuesday, reaching $50.25. The stock had a trading volume of 5,281,297 shares, compared to its average volume of 1,765,109. The stock has a 50-day moving average of $34.77 and a 200-day moving average of $28.54. The company has a market capitalization of $1.54 billion, a price-to-earnings ratio of -167.49 and a beta of 2.28. Aehr Test Systems has a 12-month low of $6.58 and a 12-month high of $53.10.

Wall Street Analyst Weigh In

Several research firms have weighed in on AEHR. William Blair upgraded shares of Aehr Test Systems from a “market perform” rating to an “outperform” rating in a research report on Monday, March 2nd. Lake Street Capital began coverage on shares of Aehr Test Systems in a research report on Wednesday, December 17th. They issued a “buy” rating on the stock. Craig Hallum reiterated a “hold” rating on shares of Aehr Test Systems in a research report on Friday, January 9th. Weiss Ratings reiterated a “sell (d)” rating on shares of Aehr Test Systems in a research report on Wednesday, January 21st. Finally, Zacks Research upgraded shares of Aehr Test Systems from a “strong sell” rating to a “hold” rating in a research report on Monday, December 8th. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $21.00.

Insider Buying and Selling at Aehr Test Systems

In related news, Director Laura Oliphant sold 4,546 shares of the firm’s stock in a transaction on Thursday, January 22nd. The shares were sold at an average price of $31.40, for a total transaction of $142,744.40. Following the completion of the transaction, the director directly owned 18,432 shares of the company’s stock, valued at approximately $578,764.80. This trade represents a 19.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Rhea J. Posedel sold 13,998 shares of the firm’s stock in a transaction on Friday, February 13th. The shares were sold at an average price of $30.02, for a total transaction of $420,219.96. Following the transaction, the director directly owned 456,979 shares of the company’s stock, valued at $13,718,509.58. The trade was a 2.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 6.80% of the company’s stock.

Hedge Funds Weigh In On Aehr Test Systems

Several institutional investors have recently bought and sold shares of AEHR. Royal Bank of Canada grew its stake in Aehr Test Systems by 262.7% during the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after acquiring an additional 36,364 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Aehr Test Systems by 8.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock valued at $126,000 after acquiring an additional 1,344 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Aehr Test Systems by 7.9% during the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock valued at $201,000 after acquiring an additional 1,145 shares in the last quarter. Legal & General Group Plc grew its stake in Aehr Test Systems by 110.8% during the second quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock valued at $89,000 after acquiring an additional 3,617 shares in the last quarter. Finally, Rhumbline Advisers grew its stake in Aehr Test Systems by 3.1% during the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock valued at $536,000 after acquiring an additional 1,254 shares in the last quarter. 69.69% of the stock is owned by hedge funds and other institutional investors.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.